PT  - JOURNAL ARTICLE
AU  - Sun, Mei
AU  - Paciga, June E.
AU  - Feldman, Richard I.
AU  - Yuan, Zeng-qiang
AU  - Coppola, Domenico
AU  - Lu, You Yong
AU  - Shelley, Sue A.
AU  - Nicosia, Santo V.
AU  - Cheng, Jin Q.
TI  - Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, Activated in Breast Cancer, Regulates and Is Induced by Estrogen Receptor α (ERα) via Interaction between ERα and PI3K
DP  - 2001 Aug 15
TA  - Cancer Research
PG  - 5985--5991
VI  - 61
IP  - 16
4099  - http://cancerres.aacrjournals.org/content/61/16/5985.short
4100  - http://cancerres.aacrjournals.org/content/61/16/5985.full
SO  - Cancer Res2001 Aug 15; 61
AB  - We have shown previously that the AKT2 pathway is essential for cell survival and important in malignant transformation. In this study, we demonstrate elevated kinase levels of AKT2 and phosphatidylinositol-3-OH kinase (PI3K) in 32 of 80 primary breast carcinomas. The majority of the cases with the activation are estrogen receptor α (ERα) positive, which prompted us to examine whether AKT2 regulates ERα activity. We found that constitutively activated AKT2 or AKT2 activated by epidermal growth factor or insulin-like growth factor-1 promotes the transcriptional activity of ERα. This effect occurred in the absence or presence of estrogen. Activated AKT2 phosphorylates ERα in vitro and in vivo, but it does not phosphorylate a mutant ERα in which ser-167 was replaced by Ala. The PI3K inhibitor, wortmannin, abolishes both the phosphorylation and transcriptional activity of ERα induced by AKT2. However, AKT2-induced ERα activity was not inhibited by tamoxifen but was completely abolished by ICI 164,384, implicating that AKT2-activated ERα contributes to tamoxifen resistance. Moreover, we found that ERα binds to the p85α regulatory subunit of PI3K in the absence or presence of estradiol in epithelial cells and subsequently activates PI3K/AKT2, suggesting ERα regulation of PI3K/AKT2 through a nontranscriptional and ligand-independent mechanism. These data indicate that regulation between the ERα and PI3K/AKT2 pathway (ERα-PI3K/AKT2-ERα) may play an important role in pathogenesis of human breast cancer and could contribute to ligand-independent breast cancer cell growth. ©2001 American Association for Cancer Research.